Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells

Gynecologic Oncology

Volumn 96, Issue 2, 2005, Pages 430-438

  Yang, Wenxuan ^a   Toffa, Samuel E ^a   Lohn, Jonathan W G ^a   Seifalian, Alexander M ^a   Winslet, Marc C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antioxidant; CD44; Gastric cancer; Glutathione; Malignant ascites; Metastases; Ovarian cancer

Indexed keywords

BUTHIONINE SULFOXIMINE; FREE RADICAL; GLUTATHIONE; HERMES ANTIGEN; HYDROXYL RADICAL; MALONALDEHYDE;

ANTIOXIDANT ACTIVITY; ARTICLE; ASCITES FLUID; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; METASTASIS POTENTIAL; NORTHERN BLOTTING; OVARY ADENOCARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; UPREGULATION;

ADENOCARCINOMA; ANTIGENS, CD44; ANTIOXIDANTS; ASCITES; BLOTTING, NORTHERN; BUTHIONINE SULFOXIMINE; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OVARIAN NEOPLASMS; OXIDATIVE STRESS; STOMACH NEOPLASMS;

EID: 12344322358     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.10.016     Document Type: Article

References (51)

1. M.J. Gardner, L.M. Jones, J.B. Catterall, and G.A. Turner Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis Cancer Lett. 91 1995 229 234
2. T. Nakashio, T. Narita, M. Sato, S. Akiyama, Y. Kasai, and M. Fujiwara The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer Anticancer Res. 17 1997 293 299
3. R.E. Durand, and E. Sham The lifetime of hypoxic human tumor cells Int. J. Radiat. Oncol. Biol. Phys. 42 1998 711 715
4. Y. Suzuki, Y. Kondo, S. Himeno, K. Nemoto, M. Akimoto, and N. Imura Role of antioxidant systems in human androgen-independent prostate cancer cells Prostate 43 2000 144 149
5. D. Adeyemo, F. Imtiaz, S. Toffa, M. Lowdell, R.G. Wickremasinghe, and M. Winslet Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein Cancer Lett. 164 2001 77 84
6. T. Higashi, N. Tateishi, A. Naruse, and Y. Sakamoto A novel physiological role of liver glutathione as a reservoir of l-cysteine J. Biochem. (Tokyo) 82 1977 117 124
7. G. Wu, Y.Z. Fang, S. Yang, J.R. Lupton, and N.D. Turner Glutathione metabolism and its implications for health J. Nutr. 134 2004 489 492
8. R.E. Howells, K.K. Dhar, P.R. Hoban, P.W. Jones, A.A. Fryer, and C.W. Redman Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer Int. J. Gynecol. Cancer 14 2004 242 250
9. J. Kigawa, Y. Minagawa, Y. Kanamori, H. Itamochi, X. Cheng, and M. Okada Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer Cancer 82 1998 697 702
10. G.M. Lewandowicz, P. Britt, A.W. Elgie, C.J. Williamson, H.M. Coley, and A.G. Hall Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer Gynecol. Oncol. 85 2002 298 304
11. M. Schmidinger, A.C. Budinsky, C. Wenzel, M. Piribauer, R. Brix, and M. Kautzky Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer Wien. Klin. Wochenschr. 112 2000 617 623
12. J.A. Drisko, J. Chapman, and V.J. Hunter The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer J. Am. Coll. Nutr. 22 2003 118 123
13. J.A. Drisko, J. Chapman, and V.J. Hunter The use of antioxidant therapies during chemotherapy Gynecol. Oncol. 88 2003 434 439
14. V.E. von Gruenigen, J.M. Jamison, J. Gilloteaux, H.E. Lorimer, M. Summers, and R.R. Pollard The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma Anticancer Res. 23 2003 3279 3287
15. K. Sieja, and M. Talerczyk Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy Gynecol. Oncol. 93 2004 320 327
16. D. Koracevic, G. Koracevic, V. Djordjevic, S. Andrejevic, and V. Cosic Method for the measurement of antioxidant activity in human fluids J. Clin. Pathol. 54 2001 356 361
17. D.W. Lamson, and M.S. Brignall Antioxidants and cancer therapy II: quick reference guide Altern. Med. Rev. 5 2000 152 163
18. D.W. Lamson, and M.S. Brignall Antioxidants in cancer therapy; their actions and interactions with oncologic therapies Altern. Med. Rev. 4 1999 304 329
19. A. Meister Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy Pharmacol. Ther. 51 1991 155 194
20. S.K. Srivastava, and E. Beutler The transport of oxidized glutathione from the erythrocytes of various species in the presence of chromate Biochem. J. 114 1969 833 837
21. J. Bautista, R. Corpas, R. Ramos, O. Cremades, J.F. Gutierrez, and S. Alegre Brain mitochondrial complex I inactivation by oxidative modification Biochem. Biophys. Res. Commun. 275 2000 890 894
22. A. Yusup, H. Upur, A. Umar, and N. Moore Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage Fundam. Clin. Pharmacol. 18 2004 471 476
23. H. Zhu, M. He, G.L. Bannenberg, P. Moldeus, and H.G. Shertzer Effects of glutathione and pH on the oxidation of biomarkers of cellular oxidative stress Arch. Toxicol. 70 1996 628 634
24. G.M. Lewandowicz, P. Britt, A.W. Elgie, C.J. Williamson, H.M. Coley, and A.G. Hall Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer Gynecol. Oncol. 85 2002 298 304
25. J.H. Waterborg, and H.R. Matthews The Lowry method for protein quantitation Methods Mol. Biol. 32 1994 1 4
26. G.R. Screaton, M.V. Bell, D.G. Jackson, F.B. Cornelis, U. Gerth, and J.I. Bell Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons Proc. Natl. Acad. Sci. U. S. A. 89 1992 12160 12164
27. J.M. Brown Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies Mol. Med. Today 6 2000 157 162
28. B.G. Wouters, S.A. Weppler, M. Koritzinsky, W. Landuyt, S. Nuyts, and J. Theys Hypoxia as a target for combined modality treatments Eur. J. Cancer 38 2002 240 257
29. D.E. Marsden, J.N. Lickiss, and N.F. Hacker Gastrointestinal problems in patients with advanced gynaecological malignancy Best Pract. Res. Clin. Obstet. Gynaecol. 15 2001 253 263
30. H. Puthalakath, D.C. Huang, L.A. O'Reilly, S.M. King, and A. Strasser The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex Mol. Cell 3 1999 287 296
31. G.F. Rush, J.R. Gorski, M.G. Ripple, J. Sowinski, P. Bugelski, and W.R. Hewitt Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes Toxicol. Appl. Pharmacol. 78 1985 473 483
32. J.N. Keller, and M.P. Mattson Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system Rev. Neurosci. 9 1998 105 116
33. M. Guven, B. Ozturk, A. Sayal, A. Ozeturk, and T. Ulutin Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis Cancer Biochem. Biophys. 17 1999 155 162
34. A. Hercbergs, F. Brok-Simoni, F. Holtzman, J. Bar-Am, J.T. Leith, and H.J. Brenner Erythrocyte glutathione and tumour response to chemotherapy Lancet 339 1992 1074 1076
35. E. Obrador, J. Navarro, J. Mompo, M. Asensi, J.A. Pellicer, and J.M. Estrela Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotoxicity: role of glutathione BioFactors 8 1998 23 26
36. J.B. Johnston, L.G. Israels, G.J. Goldenberg, C.D. Anhalt, L. Verburg, and M.R. Mowat Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia J. Natl. Cancer Inst. 82 1990 776 779
37. J.B. Mitchell, and A. Russo The role of glutathione in radiation and drug induced cytotoxicity Br. J. Cancer., Suppl. 8 1987 96 104
38. P. Terradez, M. Asensi, M.C. Lasso Dela Vega, I.R. Puertes, J. Vina, and J.M. Estrela Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth Biochem. J. 292 Pt 2 1993 477 483
39. M.C. Lasso De la Vega, P. Terradez, E. Obrador, J. Navarro, J.A. Pellicer, and J.M. Estrela Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP Biochem. J. 298 Pt 1 1994 99 105
40. E. Beutler, and T. Gelbart Plasma glutathione in health and in patients with malignant disease J. Lab. Clin. Med. 105 1985 581 584
41. B. Halliwell, and M. Whiteman Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean Br. J. Pharmacol. 142 2004 231 255
42. B.A. Runyon, J.C. Hoefs, and T.R. Morgan Ascitic fluid analysis in malignancy-related ascites Hepatology 8 1988 1104 1109
43. F. Imitiaz, Z. Dabbagh, M. Winslet, and S. Toffa The role of malignant ascites in expression of adhesion molecules on mesothelial and endothelial cells Eur. J. Surg. Oncol. 24 1998 627
44. K. Lessan, D.J. Aguiar, T. Oegema, L. Siebenson, and A.P. Skubitz CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells Am. J. Pathol. 154 1999 1525 1537
45. T. Koyama, M. Yashiro, T. Inoue, S. Nishimura, Y.S. Hirakawa, and K. Chung TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells Int. J. Oncol. 16 2000 355 362
46. S.A. Cannistra, G.S. Kansas, J. Niloff, B. De Franzo, Y. Kim, and C. Ottensmeier Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H Cancer Res. 53 1993 3830 3838
47. T. Strobel, and S.A. Cannistra Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro Gynecol. Oncol. 73 1999 362 367
48. S. Sillanpaa, M.A. Anttila, K. Voutilainen, R.H. Tammi, M.I. Tammi, and S.V. Saarikoski CD44 expression indicates favorable prognosis in epithelial ovarian cancer Clin. Cancer Res. 9 2003 5318 5324
49. A. Karadag, K.U. Ogbureke, N.S. Fedarko, and L.W. Fisher Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion J. Natl. Cancer Inst. 96 2004 956 965
50. N. Ahmed, F. Pansino, R. Clyde, P. Murthi, M.A. Quinn, and G.E. Rice Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade Carcinogenesis 23 2002 237 244
51. L. Yin, Y. Li, J. Ren, H. Kuwahara, and D. Kufe Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress J. Biol. Chem. 278 2003 35458 35464